HBEAG CONCENTRATION CAN BE USED TO PREDICT RESPONSE AND MONITOR THE EFFECTS OF TREATMENT IN CHRONIC HEPATITIS-B - A COMPARISON TO HBV DNA TESTING

被引：0
|
作者：
PERRILLO, R
MIMMS, L
SCHECHTMAN, K
ROBBINS, D
CAMPBELL, C
机构：
[1] VAMC,GASTROENTEROL SECT,ST LOUIS,MO
[2] WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,DEPT BIOSTAT,ST LOUIS,MO 63110
[4] ABBOTT LABS,N CHICAGO,IL 60064
来源：
HEPATOLOGY | 1993年 / 18卷 / 04期
关键词：
D O I：
10.1016/0270-9139(93)92111-C
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A146 / A146
页数：1
相关论文
共 50 条
  • [31] Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients
    Hadad Ivan
    World Journal of Gastroenterology, 2007, (20) : 2878 - 2882
  • [32] Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients
    Lu, Hai-Ying
    Zhuang, Li-Wei
    Yu, Yan-Yan
    Ivan, Hadad
    Si, Chong-Wen
    Zeng, Zheng
    Li, Jun
    Hou, Dong-Ming
    Chen, Xin-Yue
    Han, Zhong-Hou
    Chen, Yong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (20) : 2878 - 2882
  • [33] A linear correlation exists between hepatitis B (HBV) DNA levels and fibrosis stage in HBeAg negative but not HBeAg positive chronic hepatitis B
    Croagh, C. M.
    Bell, S. J.
    Kong, Y.
    Chen, R.
    Shaw, G.
    Demediuk, B.
    Thompson, A. J. V.
    Locarnini, S.
    Desmond, P. V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A283 - A283
  • [34] Not HBeAg-status but HBV genotype predicts response to IFN in chronic hepatitis B
    Erhardt, Andreas
    Ludwig, Amei
    Brunetto, Maurizia
    Popescu, Matei
    van Boemmel, Florian
    Siemer, Malte
    Adams, Ortwin
    Haussinger, Dieter
    HEPATOLOGY, 2007, 46 (04) : 671A - 671A
  • [35] HBeAg INDEX AND HBV DNA REDUCTION CAN PREDICT LONG TERM RESPONSE OF CHRONIC HEPATITIS B, HBeAg POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2a: A THREE-YEAR FOLLOW-UP
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Chotiyaputta, W.
    Nimanong, S.
    Tanwandee, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S203 - S204
  • [36] HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication
    Praneenararat, Surat
    Chamroonkul, Naichaya
    Sripongpun, Pimsiri
    Kanngurn, Samornmas
    Jarumanokul, Roongrueng
    Piratvisuth, Teerha
    BMC GASTROENTEROLOGY, 2014, 14
  • [37] HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication
    Surat Praneenararat
    Naichaya Chamroonkul
    Pimsiri Sripongpun
    Samornmas Kanngurn
    Roongrueng Jarumanokul
    Teerha Piratvisuth
    BMC Gastroenterology, 14
  • [38] CLINICAL-SIGNIFICANCE OF HBV DNA IN SERUM OF CHILDREN WITH CHRONIC HEPATITIS-B
    WIRTH, S
    MOLLERS, U
    SCHAEFER, E
    SCHWARZE, U
    ZABEL, B
    KLINISCHE PADIATRIE, 1992, 204 (03): : 155 - 157
  • [39] Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B
    Kwon, J. H.
    Jang, J. W.
    Lee, S.
    Lee, J.
    Chung, K. W.
    Lee, Y. S.
    Choi, J. Y.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (02) : E41 - E47
  • [40] SERUM HBV DNA LEVELS AND INFLAMMATORY ACTIVITY IN CHRONIC ACTIVE HEPATITIS-B
    WOOD, JR
    TASWELL, HF
    CZAJA, AJ
    LUDWIG, J
    CHASE, RC
    RAKELA, J
    HEPATOLOGY, 1986, 6 (05) : 1204 - 1204
12345